Sort   by:  
 Page size 
UnknownAttainment of treat-to-target endpoints in SLE patients with high disease activity in the atacicept phase 2b ADDRESS II study.
Not available
S-EPMC7516108 | biostudies-literature
UnknownConstruction of a Frailty Index as a Novel Health Measure in Systemic Lupus Erythematosus.
Not available
S-EPMC6800806 | biostudies-literature
UnknownEvaluating the Properties of a Frailty Index and Its Association With Mortality Risk Among Patients With Systemic Lupus Erythematosus.
Not available
S-EPMC6663648 | biostudies-literature
UnknownPrediction of Hospitalizations in Systemic Lupus Erythematosus Using the Systemic Lupus International Collaborating Clinics Frailty Index.
Not available
S-EPMC8096857 | biostudies-literature
UnknownRemission and low disease activity (LDA) prevent damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort.
Not available
S-EPMC10353886 | biostudies-literature
UnknownAntinuclear Antibody-Negative Systemic Lupus Erythematosus in an International Inception Cohort.
Not available
S-EPMC7268889 | biostudies-literature
UnknownGlucocorticoid use and factors associated with variability in this use in the Systemic Lupus International Collaborating Clinics Inception Cohort.
Not available
S-EPMC5888922 | biostudies-literature
UnknownMachine learning identifies clusters of longitudinal autoantibody profiles predictive of systemic lupus erythematosus disease outcomes.
Not available
S-EPMC11293954 | biostudies-literature
UnknownSeizure disorders in systemic lupus erythematosus results from an international, prospective, inception cohort study.
Not available
S-EPMC4656036 | biostudies-literature
UnknownImpact of early disease factors on metabolic syndrome in systemic lupus erythematosus: data from an international inception cohort.
Not available
S-EPMC4515988 | biostudies-literature
Sort   by:  
 Page size